跳至主要内容
临床试验/NCT05067309
NCT05067309Unknown不适用

Termination of Early Pregnancy in Scarred Uterus With Letrozole and Misoprostol Compared to Misoprostol Alone

Ahmed Elsayed Aref1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2021年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
1
试验地点
1
主要终点
Complete abortion of early pregnancy with letrozole then misoprostol

研究概览

简要总结

Termination of early pregnancy in scarred uterus with letrozole and misoprostol compared to Misoprostol alone

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • Minimum age of 18 years for mother.
  • Non-viable fetus (missed abortion or blighted ovum) in the 1st trimester of pregnancy evidenced by criteria for diagnosis by TVS .
  • Previous C.S or Myomectomy (1 or more )
  • lack of any maternal diseases such as: heart disease, asthma, history of thromboembolism, cancer, renal failure, and liver diseases.

排除标准

  • * Medical problem in patient
  • Emergency conditions which need intervention .
  • History of allergy to misoprostol or letrozole drugs.

研究组 & 干预措施

Missed abortion received letrozole then misoprostol

干预措施: Letrozole 2.5mg (Drug)

结局指标

主要结局

Complete abortion of early pregnancy with letrozole then misoprostol

时间窗: 6 months

Letrozole increase cervical ripening

次要结局

未报告次要终点

研究者

发起方
Ahmed Elsayed Aref
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ahmed Elsayed Aref

Ahmed Elsayed Aref

Sohag University

研究点 (1)

Loading locations...

相似试验